← Leaderboards
Lisbeth Sanders
Lifebio Inc
$3,888,046
Attributed
$4,341,616
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,341,616 · 3
By mechanism
R44$3,398,992 · 1
R43$942,624 · 2
Top collaborators
- Kyeung Mi Oh1 shared
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposUsabilityCaregiversLifeS DiseaseDesignSmall Business Innovation Research GrantDementiaPersonsPerson CenteredS Disease Related DementiaFeedbackPrototypeCaringParticipantResidential TreatmentPsychological SymptomDigitalQuality Of LifeAssisted Living FacilitiesMusicArtificial IntelligenceCognitionImpaired Cognition
Grant awards (6)
LifeBio Memory: Development of a reminiscence therapy online platform with machine learning to increase engagement$907,141
R44 · FY2025 · AG · contact PI
LifeBioTALK: Digital Engagement with a Pre-Scripted Avatar for People with Alzheimer's Disease to Reduce Challenging Behaviors and Caregiver Burden$61,825
R43 · FY2025 · AG · contact PI
LifeBioTALK: Digital Engagement with a Pre-Scripted Avatar for People with Alzheimer's Disease to Reduce Challenging Behaviors and Caregiver Burden$432,337
R43 · FY2024 · AG · contact PI
Development of a reminiscence therapy online platform with machine learning to increase engagement with people living with dementia and their care partners$1,107,603
R44 · FY2021 · AG · contact PI
LifeBio-ALZ: AI driven digital biomarker engine leveraging natural conversation to widely scale accessibility for early detection and assessment of Alzheimers disease progression$448,462
R43 · FY2021 · AG · contact PI
Development of a reminiscence therapy online platform with machine learning to increase engagement with people living with dementia and their care partners$1,384,248
R44 · FY2020 · AG · contact PI